Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × trebananib × Clear all

Phase

Status

Completed 22 Terminated 2 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cisplatin 457 Radiotherapy 333 Cyclophosphamide 318 Carboplatin 312 Paclitaxel 296 Capecitabine 292 Oxaliplatin 284 Docetaxel 275 Gemcitabine 270 Fluorouracil 247 apatinib 225 Drug Therapy 224 Bevacizumab 204 camrelizumab 186 Etoposide 176 Irinotecan 159 Doxorubicin 155 Dexamethasone 135 Leucovorin 134 Cytarabine 130 Blood Specimen Collection 129 pembrolizumab 123 Neoadjuvant Therapy 122 sintilimab 116 Pemetrexed 116 anlotinib 114 toripalimab 110 S 1 (combination) 110 Rituximab 110 Surgical Procedures, Operative 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01249521 2010-11-30

Vengeance

Austin Health

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡